- $134.12m
- $127.75m
- $7.14m
- 46
- 34
- 91
- 57
Annual balance sheet for CervoMed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14.2 | 18.5 | 37.3 | 22.5 | 7.79 |
Net Total Receivables | — | — | — | — | 0.915 |
Prepaid Expenses | |||||
Total Current Assets | 14.6 | 18.8 | 37.8 | 22.6 | 9.96 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.499 | 0.298 | 0 | — | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 24.1 | 27.7 | 37.8 | 22.6 | 9.97 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 1.72 | 2.44 | 2.93 | 2.42 | 2.6 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.98 | 2.92 | 2.93 | 2.42 | 2.6 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 20.1 | 24.8 | 34.9 | 20.2 | 7.38 |
Total Liabilities & Shareholders' Equity | 24.1 | 27.7 | 37.8 | 22.6 | 9.97 |
Total Common Shares Outstanding |